From the *Division of Pediatric Infectious Diseases and Immunology and Division of Neonatology and Pediatric Intensive Care, Department of Pediatrics, University of Würzburg, Würzburg, Germany; †Department of Pediatric Pneumology and Immunology, Charité Children’s Hospital; ‡Division of Immunology, Labor Berlin; §Institute of Medical Immunology, Charité, Campus Virchow Klinikum; ¶Medical Department I, Charité—Universitätsmedizin Berlin, Campus Benjamin Franklin, Berlin, Germany; and ‖Institute for Clinical Transfusion Medicine and Immunogenetics, Ulm, German Red Cross Blood Service, Baden-Württemberg-Hessen, and Institute for Transfusion Medicine, University Hospital Ulm, Ulm, Germany.
Accepted for publication March 08, 2013.
O.A., Ka.St., H.v.B. and J.L. contributed equally to this publication.
H.v.B. received a grant (BE-3895/3-1) from the Deutsche Forschungsgemeinschaft and a grant from the Sonnenfeldstiftung. The authors have no other funding or conflicts of interest to disclose.
Supplemental digital content is available for this article. Direct URL citations appear in the printed text and are provided in the HTML and PDF versions of this article on the journal’s website (www.pidj.com).
Address for correspondence: Oliver Andres, MD, Division of Neonatology and Pediatric Intensive Care, University Children’s Hospital, Josef-Schneider-Straße 2, 97080 Würzburg, Germany. E-mail: [email protected].
